Core Viewpoint - Fujian Wancheng Biotechnology Group Co., Ltd. plans to issue H shares and apply for listing on the Hong Kong Stock Exchange to enhance its international strategy, brand recognition, and overall competitiveness [1][2]. Group 1: Meeting Details - The 31st meeting of the 4th Supervisory Board was held on August 22, 2025, with all three participating supervisors present [1]. - The meeting was conducted in accordance with the Company Law and the company's articles of association [1]. Group 2: H Share Issuance Proposal - The Supervisory Board approved the proposal for issuing H shares and listing on the Hong Kong Stock Exchange, with a unanimous vote of 3 in favor [2]. - The shares will be ordinary shares with a par value of RMB 1, issued in foreign currency [2]. Group 3: Issuance Method and Scale - The issuance will include both public offerings in Hong Kong and international placements, with the total number of H shares not exceeding 15% of the company's total share capital post-issuance [3][4]. - The pricing will be determined based on market conditions and investor acceptance, utilizing a market-oriented pricing approach [4]. Group 4: Fund Utilization Plan - The funds raised will be used for store network expansion, product development, brand building, supply chain upgrades, digital capabilities enhancement, and general corporate purposes [8]. - The Board is authorized to adjust the use of funds based on regulatory feedback and operational needs [8]. Group 5: Approval and Compliance - The issuance plan requires approval from the shareholders' meeting and must comply with relevant regulations from the China Securities Regulatory Commission and the Hong Kong Stock Exchange [2][6]. - The validity period for the resolutions related to the issuance is set for 24 months from the date of approval by the shareholders' meeting [9]. Group 6: Additional Proposals - The Supervisory Board approved the proposal for the distribution of retained earnings before the issuance, ensuring that both existing and new shareholders share the profits proportionally after the issuance [10]. - The Board also approved the hiring of an auditing firm for the issuance process, specifically FuRui MaZe Accounting Firm [10].
万辰集团: 第四届监事会第三十一次会议决议公告